C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher & educator. He is the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School.
The institutes have led over 1,000 studies, published 5,500 manuscripts in the peer review literature (including 144 in the New England Journal) and have led 60 FDA submissions from their network of 7,000 sites worldwide. In 2014 and 2018 - 2020 Gibson was ranked as one of the world's most highly cited authors in all of science in the past decade by Thomson Reuters. In 2021, he was named one of the Fifty of the Most Influential Voices in Healthcare by Medika Life. His work has been cited over 136,000 times, and he has an H index of 129 and an i10-index of 523.

No relationships to disclose

Presentation(s):

• SESSION I: SELECTED WORKING GROUP UPDATES & FOCUS 2024

  Saturday, March 9, 2024
  1:05 PM - 2:05 PM ET

• Discussion Panel

  Saturday, March 9, 2024
  1:45 PM - 2:05 PM ET

• Discussion Panel

  Saturday, March 9, 2024
  4:05 PM - 4:30 PM ET

• Overview Discussion, Comments & Next Steps

  Saturday, March 9, 2024
  6:40 PM - 7:00 PM ET

• ACS and AMI Management [Non-CME]

  Saturday, March 9, 2024
  2:00 PM - 6:00 PM ET

• Pre-Hospital Therapy in STEMI

  Saturday, March 9, 2024
  2:48 PM - 2:56 PM ET

• Uncoupling Thrombosis and Hemostasis: Factor XI Inhibition Without Bleeding

  Saturday, March 9, 2024
  3:49 PM - 3:57 PM ET

• Infusing ApoA1 After a Heart Attack

  Saturday, March 9, 2024
  5:16 PM - 5:24 PM ET

• CARDIOTUBE INTERVIEW - Impact of Evouqe and TriClip Approval on Management of TR

  Sunday, March 10, 2024
  9:15 AM - 9:30 AM ET

• CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: The Association of Socioeconomic Status with Procedural Management and Mortality After Percutaneous Coronary Intervention: An Observational Study from the Pan-London PCI Registry

  Sunday, March 10, 2024
  9:30 AM - 9:45 AM ET

• CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: Computed Tomography Cardiac Angiography Prior to Invasive Coronary Angiography in Patients with Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilisation, and Long-Term Cardiac Events from the BYPASS-CTCA Trial

  Sunday, March 10, 2024
  9:45 AM - 10:00 AM ET

• CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: Time-Dependent Outcomes with the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-Up: Final Report from the ABSORB Trial Program

  Sunday, March 10, 2024
  10:00 AM - 10:15 AM ET

• CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: Immediate Versus Staged Complete Revascularization in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease: 2-Year Follow-Up of the Multicentre Randomized Controlled BIOVASC Trial

  Sunday, March 10, 2024
  10:15 AM - 10:30 AM ET

• CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: Artificial Intelligence System for Identifying and Notifying Hazardous Situations in the Catheterization Laboratory

  Sunday, March 10, 2024
  10:30 AM - 10:45 AM ET

• Keynote Lecture 2 | Impact of Social Media on Research and Education in Cardiology

  Sunday, March 10, 2024
  11:54 AM - 12:05 PM ET

• Biological Basis and Proposed Mechanism of Action of CSL112 (apolipoprotein A-I [human]) for Prevention of Major Adverse Cardiovascular Events in Patients with Myocardial Infarction

  Sunday, March 10, 2024
  5:00 PM - 5:08 PM ET

• OPTIMIZATION OF THERAPY FOR CAD PATIENTS WITH PHARMACOTHERAPY [CME] – Supported Through an Educational Grant by Chiesi USA, Inc.

  Sunday, March 10, 2024
  7:00 PM - 9:00 PM ET

• Panel Discussion

  Sunday, March 10, 2024
  7:40 PM - 7:50 PM ET

• Panel Discussion

  Sunday, March 10, 2024
  8:10 PM - 8:25 PM ET

• Will Factor XI Inhibitors Be A Game Changer for Patients Who Need Anticoagulation?

  Sunday, March 10, 2024
  8:35 PM - 8:45 PM ET

• Q&A with the Panel

  Sunday, March 10, 2024
  8:45 PM - 9:00 PM ET

• Late-Breaking Artificial Intelligence Clinical Trials [Non-CME]

  Monday, March 11, 2024
  8:00 AM - 9:00 AM ET

• Panel Discussion | Questions from the Audience

  Monday, March 11, 2024
  3:54 PM - 4:10 PM ET

• The Digital Health Revolution and Its Clinical Trial Impact

  Tuesday, March 12, 2024
  10:30 AM - 10:38 AM ET

• Panel Discussion: Digital Heath Apps in Clinical Trials: Ready for Prime Time?

  Tuesday, March 12, 2024
  10:54 AM - 11:32 AM ET